{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:05:36Z","timestamp":1780362336735,"version":"3.54.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113937","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T20:14:51Z","timestamp":1418415291000},"page":"e113937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arthritis Patients"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct01313520","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kenzie D.","family":"MacIsaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Loboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Peterfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Riek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Beals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"KL Hyrich","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygeno.2009.08.008","article-title":"Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response","volume":"94","author":"JR Bienkowska","year":"2009","journal-title":"Genomics"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007556","article-title":"An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis","volume":"4","author":"A Juli\u00e0","year":"2009","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1186\/ar2419","article-title":"Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept","volume":"10","author":"D Koczan","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1186\/ar1990","article-title":"Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis","volume":"8","author":"T Lequerre","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/rheumatology\/ken083","article-title":"Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab","volume":"47","author":"N Sekiguchi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/clpt.2009.244","article-title":"CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis","volume":"87","author":"B Stuhlmuller","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.06.149","article-title":"Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells","volume":"387","author":"M Tanino","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1186\/ar2912","article-title":"Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment","volume":"12","author":"LG van Baarsen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref10","article-title":"Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis","volume":"7","author":"EJM Toonen","year":"2012","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/rheumatology\/keh140","article-title":"Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis","volume":"43","author":"V Strand","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0730-725X(98)00008-3","article-title":"Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation","volume":"16","author":"M Ostergaard","year":"1998","journal-title":"Magn Reson Imaging"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mrm.20597","article-title":"Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters","volume":"54","author":"DW Workie","year":"2005","journal-title":"Magn Reson Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/kem250","article-title":"MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy","volume":"47","author":"RJ Hodgson","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref16","first-page":"1387","article-title":"OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module","volume":"30","author":"F McQueen","year":"2003","journal-title":"J Rheumatol"},{"key":"ref17","first-page":"134","article-title":"Longitudinal data analysis ofcontinuous and discrete responses for pre-post designs","volume":"62","author":"ZS Liang KY","year":"2000","journal-title":"Indian Journal of Statistics"},{"key":"ref18","first-page":"93","article-title":"The Disease Activity Score and the EULAR response criteria","volume":"23","author":"J Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Y Okada","year":"2014","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"K Van Steendam","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref21","first-page":"1817","article-title":"Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate","volume":"34","author":"A Parker","year":"2007","journal-title":"J Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/14728222.2014.930440","article-title":"SDF-1 signaling: a promising target in rheumatic diseases","volume":"18","author":"A Villalvilla","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2008.093153","article-title":"Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis","volume":"68","author":"C Trocme","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"D Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2217\/pgs.11.114","article-title":"Genetic and genomic predictors of anti-TNF response","volume":"12","author":"R Prajapati","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/rheumatology\/kem109","article-title":"Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis","volume":"46","author":"MC Greenwood","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.30402","article-title":"American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010","volume":"63","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/annrheumdis-2012-202696","article-title":"MRI comes of age in RA clinical trials","volume":"72","author":"C Peterfy","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.38083","article-title":"Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis","volume":"65","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/03009742.2012.723745","article-title":"Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis","volume":"42","author":"MB Axelsen","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/ard.2007.077271","article-title":"Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis","volume":"67","author":"R Hodgson","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00296-012-2658-z","article-title":"Comparison of OMERACT-RAMRIS scores and computer-aided dynamic magnetic resonance imaging findings of hand and wrist as a measure of activity in rheumatoid arthritis","volume":"33","author":"S Orguc","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2249.2012.04626.x","article-title":"Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients","volume":"170","author":"LR Coulthard","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2011-11-391342","article-title":"Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells","volume":"120","author":"KA Oduro","year":"2012","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood.V76.10.1989.1989","article-title":"Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor","volume":"76","author":"T Leizer","year":"1990","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.141.10.3410","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo","volume":"141","author":"K Kaushansky","year":"1988","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrrheum.2012.118","article-title":"Platelets: active players in the pathogenesis of arthritis and SLE","volume":"8","author":"E Boilard","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood-2005-03-1247","article-title":"Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure","volume":"106","author":"P Pignatelli","year":"2005","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000204114","article-title":"Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis","volume":"93","author":"K Dan","year":"1995","journal-title":"Acta Haematol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/CJI.0b013e3181826d72","article-title":"Phase 2 trial of recombinant tumor necrosis factor-alpha in combination with dactinomycin in children with recurrent Wilms tumor","volume":"31","author":"HJ Meany","year":"2008","journal-title":"J Immunother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/cyto.2002.0889","article-title":"Activation of platelet caspases by TNF and its consequences for kinetics","volume":"18","author":"PF Piguet","year":"2002","journal-title":"Cytokine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.4049\/jimmunol.160.12.6182","article-title":"Role of TNFR1 and TNFR2 in TNF-induced platelet consumption in mice","volume":"160","author":"F Tacchini-Cottier","year":"1998","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.20031104","article-title":"Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression","volume":"199","author":"Y Ueda","year":"2004","journal-title":"J Exp Med"},{"key":"ref44","first-page":"191","article-title":"Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF\u03b1 blocker failure","volume":"6","author":"J Kekow","year":"2012","journal-title":"Biologics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T21:18:47Z","timestamp":1717622327000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113937"}},"subtitle":[],"editor":[{"given":"Arvind","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}